Gene expression of prothrombin in human and rat kidneys: Basic and clinical approach

Journal of the American Society of Nephrology

Volumn 10, Issue SUPPL. 14, 1999, Pages

  Suzuki, Koji ^a   Tanaka, Tatsuro ^a   Miyazawa, Katsuhito ^a   Nakajima, Chiaki ^a   Moriyama, Manabu ^a   Suga, Kodai ^a   Murai, Masatoshi ^b   Yano, Junichi ^b  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b NIPPON SHINYAKU CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHILIN; MESSENGER RNA; PROTHROMBIN; THROMBIN;

ADULT; ANIMAL CELL; ANIMAL TISSUE; CONFERENCE PAPER; DNA SEQUENCE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY TUBULE; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SEQUENCE HOMOLOGY; STONE FORMATION;

EID: 0032754107     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Doyle IR, Ryall RL, Marshall VR: Inclusion of proteins into calcium oxalate crystals precipitated from human urine: A highly selective phenomenon. Clin Chem 37: 1589-1594, 1991
2. Suzuki K, Moriyama M, Nakajima C, Kawamura K, Miyazawa K, Tsugawa R, Kikuchi N, Nagata K: Isolation and partial characterization of crystal matrix protein as a potent inhibitor of calcium oxalate crystal aggregation: Evidence of activation peptide of human prothrombin. Urol Res 22: 45-50, 1994
3. Stapleton AMF, Simpson RJ, Ryall RL: Crystal matrix protein is related to human prothrombin. Biochem Biophys Res Commun 195: 1199-1203, 1993
4. Suzuki K, Miyazawa K, Tsugawa R: Crystal matrix protein is related to activation peptide (F1) of human prothrombin. In: Urolithiasis 1996, edited by Pak CYC, Resnick MI, Preminger GM, Dallas, TX, Millet the Printer, 1996, pp 224-225
5. Liebman HA, Furie BC, Tong MJ, Tong MJ, Blanchard RT, Lo KJ, Lee SD, Coleman MS, Furie B: Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 310: 1427-1431, 1984
6. Nakajima C, Suzuki K, Tsugawa R: Inhibitory potency of crystal matrix protein on the crystallization of calcium oxalate. Int J Urol 3[Suppl 1]: s76-s79, 1996
7. Moriyama M, Suzuki K, Tsugawa R: Immunohistochemical study using anti-PIVKA-II monoclonal antibody in human kidney tissues. J Kanazawa Med Univ 20: 42-50, 1995
8. Stapleton AMF, Seymour AE, Brennan JS, Doyle IR, Marshall VR, Ryall RL: Immunohistochemical distribution and quantification of crystal matrix protein. Kidney Int 44: 817-824, 1993
9. Stapleton AMF, Timme TL, Ryall RL: Gene expression of prothrombin in the human kidney and its potential relevance to kidney stone disease. Br J Urol 81: 666-671, 1998
10. Okada Y, Kawamura J, Kuo YJ, Yoshida O: Experimental model for calcium oxalate urolithiasis. In: Urinary Stones, edited by Ryall RL, Brockis JG, Marshall V, Finlayson B, New York, Churchill Livingstone, 1984, pp 378-383
11. Degen SJ, MacGillivray RT, Davie EW: Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin. Biochemistry 22: 2087-2097, 1983
12. Degen SJF: The prothrombin gene and its liver-specific expression. Semin Thromb Hemostasis 18: 230-242, 1992
13. Degen SJ, Davie EW: Nucleotide sequence of the gene for human prothrombin. Biochemistry 26: 6165-6177, 1987
14. Jamison CS, Degen SJF: Prenatal and postnatal expression of mRNA coding for rat prothrombin. Biochim Biophys Acta 1088: 208-216, 1991